In-vitro evaluation cell model of skin sensitization of compound and construction method of cell model

A technology of cell model and construction method, applied in the field of genetic engineering, can solve problems such as difficult quantitative evaluation of sensitization strength

Active Publication Date: 2018-06-01
SOUTH CHINA UNIV OF TECH
View PDF2 Cites 37 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] However, these reporter cell models only indirectly reflect target gene expression, rather than real-time reporter gene expression
The essence of the model is a transgenic cell in which the regulatory element-luciferase is randomly inserted. Although the cell can indirectly evaluate the expression of the target gene through the expression of luciferase to a certain extent, it is not a real reporter cell that tracks the expression of the endogenous gene synchronously. As a result, the model can only evaluate whether the compound is sensitized, and it is difficult to quantitatively evaluate the sensitization strength

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • In-vitro evaluation cell model of skin sensitization of compound and construction method of cell model
  • In-vitro evaluation cell model of skin sensitization of compound and construction method of cell model
  • In-vitro evaluation cell model of skin sensitization of compound and construction method of cell model

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0045] In the embodiment of the present invention, the CRISPR / CAS9-mediated method for constructing a HaCaT cell model in which the HMOX1 gene is targeted to knock in the luciferase gene is used for non-diagnostic or therapeutic purposes, including the following steps:

[0046] 1. Design a target-specific sgRNA for the HMOX1 gene, construct its expression vector, and test the effectiveness of target cleavage.

[0047] For the vicinity of the gene stop codon of HMOX1 (NCBI accession number: NG_023030HMOX1), a specific sgRNA was designed, and off-target analysis was performed to screen three sgRNAs with good specificity and low off-target. The design results are shown in Table 1.

[0048]Table 1 Specific sgRNA sequences

[0049] name

sgRNA sequence (5'-3')

genomic location

sgRNA-1

TTAACAGGTGGGCGTGCATCAGG

Exon 5

sgRNA-10

GGTCCTTACACTCAGCTTTCTGG

Exon 5

sgRNA-13

GCTTTATGCCATGTGAATGCAGG

Exon 5

[0050] The U6 promot...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an in-vitro evaluation cell model of skin sensitization of a compound and a construction method of the cell model. The construction method of the cell model comprises the following steps of: designing and constructing an sgRNA (small guide ribonucleic acid) expression vector with CRISPR / Cas9 (clustered regularly interspaced short palindromic repeats / CRISPR associated protein 9), designing and constructing a homologous recombinant vector capable of knocking a reporter gene connected with a spontaneous lysis peptide sequence into an expression cassette of an HMOX1 (heme oxygenase (decycling) 1) gene, and cotransfecting a cell with the homologous recombinant vector, hCas9 (humanized Cas9) plasmid and the sgRNA expression vector for monoclone enlarging culture to form the cell model. The HaCaT cell model with a luciferase gene knocked in before a termination codon of the HMOX1 gene by a combined CRISPR / CAS9 cell monoclone technology. The cell model achieves synchronous expression of the luciferase gene and the HMOX1 gene, so that a sensitization compound and a non-sensitization compound are effectively differentiated, and the more specific and sensitive cell model is provided for compound sensitization studies.

Description

technical field [0001] The present invention relates to the field of genetic engineering, in particular to a compound skin sensitization evaluation cell model in vitro and its construction method, in particular to a CRISPR / CAS9-mediated HMOX1 gene targeted knock-in reporter gene cell model and its method. Background technique [0002] Skin sensitization is a delayed hypersensitivity reaction caused by skin contact with elicitors. The sensitizing compound combines with endogenous proteins to form a hapten, which causes the activation of skin dendritic cells and a series of reactions in keratinocytes, which in turn activates T cells, resulting in Lymph node hyperplasia and body skin inflammation, this process is also called skin sensitization harmful outcome pathway AOP. [0003] Animal experiments for skin sensitization mainly include guinea pig skin test and local lymph node assay (LLNA) in mice. Among them, the improved version of tracer LLNA:BrdU ELISA has become the most ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/85C12N15/90C12N5/10C12Q1/02
CPCG01N33/5044G01N33/5047C12N5/0629C12N5/0639C12N5/0645C12N9/22C12N15/85C12N15/907C12N2503/00C12N2510/00C12N2800/107C12N2810/10C12N15/11C12N2310/20C12N2502/99C12N2503/02G01N33/5008C12N15/90C12N2800/80C12N2015/8527C12N2015/859C12Q1/6897C12Y114/99003
Inventor 黄黎珍钟国瑞李浩健谢水林庞士慧白静何昌生都心怡张琪霄王海杰杜红丽
Owner SOUTH CHINA UNIV OF TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products